Skip to main content
NORTHEAST PHARMACEUTICAL GROUP CO.,LTD logo

NORTHEAST PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 000597 ISIN · CNE0000009G0 LEI · 300300HX6JTMOEENF158 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,606 across all filing types
Latest filing 2025-06-10 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 000597

About NORTHEAST PHARMACEUTICAL GROUP CO.,LTD

https://www.nepharm.com.cn

Northeast Pharmaceutical Group Co., Ltd. (NEPG) specializes in the research, development, manufacture, and distribution of active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates as a large-scale integrated pharmaceutical enterprise with a diverse product portfolio encompassing vitamins, antibiotics, cardiovascular agents, and digestive system medications. NEPG is recognized as a global leader in the production of Vitamin C and Vitamin B1, alongside significant output in caffeine and fosfomycin. Its manufacturing facilities adhere to international quality standards, including Good Manufacturing Practice (GMP) certifications. The company serves a broad international market, exporting products to numerous countries while maintaining a strong domestic presence. NEPG focuses on technological innovation and industrial scaling to provide high-quality chemical raw materials and pharmaceutical preparations for global healthcare needs.

Recent filings

Filing Released Lang Actions
关于控股股东一致行动人增持计划实施完成的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the completion of a share increase plan by a controlling shareholder's concerted party. It details the shareholding changes, the purpose, amount, and method of the share increase, and includes legal opinions and compliance statements. There are no financial statements or detailed financial performance data. The document is primarily about a shareholding change and the completion of a share purchase plan by insiders. This fits the category of Transaction in Own Shares (POS), which covers company buybacks or share repurchases by controlling parties. The document length is 2633 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the correct classification is POS with high confidence.
2025-06-10 Chinese
独立董事提名人声明与承诺（曹越）
Board/Management Information Classification · 95% confidence The document is a formal statement and commitment by the nominator regarding the nomination of an independent director candidate for the company's board. It details the qualifications, compliance with legal and regulatory requirements, and declarations about the nominee's independence and suitability. There are no financial statements, earnings data, or report summaries. The content is focused on board/management information, specifically about director nomination and related compliance. Therefore, it fits the category of Board/Management Information (MANG). The document length is moderate and contains detailed declarations rather than a brief announcement or a report publication notice.
2025-06-04 Chinese
第十届董事会第三次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolutions passed at the third meeting of the tenth board of directors of Dongbei Pharmaceutical Group Co., Ltd. It details the election and changes of board members, voting results, and references other announcements for further details. The content focuses on board/management changes and meeting resolutions rather than financial data or reports. The document length is short (1061 characters) and it is clearly an announcement of board decisions, not a full report or financial statement. Therefore, it fits the category of Board/Management Information (MANG).
2025-06-04 Chinese
关于补选公司第十届董事会独立董事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of an independent director and the nomination of a new independent director to the company's board. It includes details about the director's qualifications, independence, and compliance with relevant laws and stock exchange rules. There are no financial statements, earnings data, or detailed financial analysis present. The document is a formal announcement about changes in the company's board of directors, specifically about the election and resignation of independent directors. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not a report or a presentation but an official announcement of board changes.
2025-06-04 Chinese
关于公司原料药磷霉素氨丁三醇收到欧洲药品质量管理局签发CEP证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a CEP certificate from the European Directorate for the Quality of Medicines (EDQM) for a pharmaceutical raw material product. It describes the certificate details, product information, and the impact on the company. The document is short (783 characters) and serves as a formal notification to investors about a regulatory milestone rather than a financial report or detailed filing. It does not contain financial data, management changes, voting results, or other report types. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-06-04 Chinese
独立董事候选人声明与承诺（曹越）
Board/Management Information Classification · 95% confidence The document is a detailed declaration and commitment statement by a candidate for an independent director position at a company. It includes statements about qualifications, compliance with laws and regulations, and commitments related to the role of an independent director. There is no financial data, no report of financial results, no voting results, no management changes announcement, and no regulatory filing of a financial nature. This document is related to board/management information specifically about a director candidate's declaration and commitment. Therefore, it fits best under the category of Board/Management Information (MANG). The document length and content support this classification with high confidence.
2025-06-04 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.